Problem: Beginning with the Indications for Use and supporting safety data submitted by Foundation Medicine to obtain Premarket Approval (see Supporting Materials), comment on the strategic challenges associated with obtaining FDA approval of companion diagnostics that utilize Next Generation Sequencing.